Shares of Marksans Pharma Ltd climbed 2.92% to ₹257.25 in early trade on Wednesday, June 11, following a significant block deal executed in Tuesday’s session. According to exchange data, around 1.02 crore shares changed hands at an average price of ₹249.95 per share, amounting to a transaction value of approximately ₹257 crore.
While the names of the buyers and sellers remain undisclosed, CNBC-TV18 had earlier reported that global healthcare investment firm OrbiMed Asia IV Mauritius FVCI Ltd was planning to offload up to 2.27% stake in the company via block deals. The anticipated deal size was estimated at ₹256.8 crore.
OrbiMed held a 10.88% stake in Marksans Pharma as per the March 2025 quarter shareholding pattern. The stock is drawing attention from market participants following the development, with trading volumes above average.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
Ahmedabad Plane Crash